Eye Drop Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2017-2027 Segmented By Type (Prescription v/s Over-the-Counter), By Drug Class (Anti-allergy, Anti-glaucoma, Anti-inflammatory, Anti-VEGF, and Others), By Disease Indication (Eye Allergy, Glaucoma, Eye Infections, Dry Eye Diseases, and Retinal Disorders), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region

  • Industry : Healthcare
  • Pages : 110
  • Published Date : April, 2022
Customization Enquiry

Buy Now

Summary

Report Description

Global Eye Drop Market stood at USD13530 million in 2021 and is expected to grow at a steady CAGR of 6.46% during the forecast period. This is due to the increasing frequency of many infectious diseases around the world. Furthermore, the sudden onset and spread of the COVID-19 pandemic has resulted in an upsurge in demand for eye drops used to treat COVID-19-related ocular allergies. This, in turn, supported market expansion in 2020.

Rising public awareness of the importance of eye care, widespread adoption of digital devices, an increase in the number of cataract and other eye-related surgeries that necessitate the use of eye drops after surgery, and an increase in the geriatric population, who are more susceptible to eye diseases, will all contribute to market growth in the coming years. Also, flourishing healthcare industry and increasing healthcare expenditure by both the governments and population across the globe is expected to foster the market growth during the forecast period.

Sudden Outbreak & Spread of COVID-19 Driving Market Growth

The growing number of people infected by the virus significantly changed the scenario of medical care across the world. Certain eye drops considered beneficial in the prevention of SARS-CoV-2 infection via the surface of the eye. For instance, Trehalose is a common ocular pharmaceutical drug that is used as an eye drop.

Trehalose is a basic plant-based sugar that has been shown to influence autophagy. It has antiviral effects, such as inducing type 1 interferons and aiding intracellular virus lysosomal breakdown. It also blocks clathrin-mediated viral endocytosis and prevents fusion of viral and host cell endosomal membranes by preventing endosomal acidification.

Growing Prevalence of Dry Eye Disease Supporting Market Growth

The growing case of Dry eye disease enhance the growth rate of Eye Drop Market globally. For instance, in 2021, according to National Center for Biotechnology Information, global dry eye disease was estimated at 11.59%. For symptomatic disease, the estimate was 9.12% with women 9.5% and men 6.8% (SD = 0.06).

The prevalence was lowest in North America, with 4.6% and highest in Africa with 47.9%. For signs, the prevalence was 35.2% with woman 34.7% and men 37.6%. North America showed the lowest regional prevalence, with 3.5% and Eastern Asia the highest with 42.8%.

Launching of New Eye Drops Aids Market Growth

Various Eye care companies are launching new and effective eye drops in the market for the treatment of various eye related diseases and disorders to meet the demand of the consumers. For Instance, in 2021, Nova Bay Pharmaceuticals announced the launch of Avenova Lubricating Eye Drops for the treatment of dry eye symptoms.

Also, in October 2021, Allergan, an AbbVie company, announced the FDA approval of the eye drop, Vuity, for the treatment of presbyopia which could replace reading glasses for millions.

Increasing Healthcare Expenditure to Support Market Growth

The existing healthcare industry is predicted to benefit from rising healthcare expenditures in various countries throughout the world. This, in turn, is predicted to have a positive impact on market growth through 2027. According to the WHO, worldwide healthcare spending was over USD8.3 trillion in 2018, accounting for about 10% of global GDP, and is anticipated to reach USD10 trillion by 2024.

The sudden out break and spread of the COVID-19 pandemic, on the other hand, raised demand for healthcare services, while spending on lifestyle and other diseases decreased across countries. Because of rising demand for other healthcare services, this expenditure is likely to rise in the coming years, creating potential for the Global Eye Drop Market.


Click here to download the sample

Market Segmentation

The Global Eye Drop Market is segmented based on type, drug class, disease indication, distribution channel, company, and regional distribution.

Based on type, the market can be split into Prescription and Over-the-Counter.

Based on Drug Class, the market can be divided into Anti-allergy, Anti-glaucoma, Anti-inflammatory, Anti-VEGF, and Others.

Based on disease indication, the market is divided into Eye Allergy, Glaucoma, Eye Infections, Dry Eye Diseases, and Retinal Disorders.

Based on the Distribution Channel, the market segmented into Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy.

Company Profiles

Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc. are among the major market players in the global platform that lead the market growth of the global Eye Drop Market.

Attribute

Details

Market size value in 2021

USD 13530.00 Million

Revenue Forecast in 2027

USD 19758.00 Million

United States Market size value in 2021

USD 4001.46 Million

Growth Rate

6.46%

Base Year

2021

Historical Years

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Type

·         Drug Class

·         Disease Indication

·         Distribution Channel

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; Russia Federation; United Kingdom; Germany; France; Spain; Italy; China; India; Japan; Australia; South Korea; Indonesia; Brazil; Argentina; Colombia; Turkey; South Africa; Saudi Arabia; UAE; Kuwait

Key Companies Profiled

Johnson & Johnson Inc, Genentech, Inc. (Roche), Alcon Inc., Pfizer, Inc., Bausch Health Companies, Inc., Bayer Corporation, Allergan, Inc. (AbbVie), Abbott Laboratories, Inc., KC Pharmaceuticals, Inc., Akorn, Inc

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope:

In this report, Global Eye Drop Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Eye Drop Market, By Type:
    • Prescription
    • Over-The-Counter
  • Eye Drop Market, By Drug Class:
    • Anti-allergy
    • Anti-glaucoma
    • Anti-inflammatory
    • Anti-VEGF
    • Others
  • Eye Drop Market, By Disease Indication:
    • Eye Allergy
    • Glaucoma
    • Eye Infections
    • Dry Eye Diseases
    • Retinal Disorders
  • Eye Drop Market, By Distribution Channel:
    • Hospitals Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Eye Drop Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Russia Federation
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Indonesia
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • Turkey
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Eye Drop Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Eye Drop Market

5.    Voice of Customer

5.1.  Brand Awareness

5.2.  Factors Contributing to demand for Eye Drops

5.3.  Demand, By Drug Class

5.4.  Demand, By Disease Indication

5.5.  Preference, By Distribution Channel

6.    Global Eye Drop Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type (Prescription v/s Over-The-Counter)

6.2.2.     By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)

6.2.3.     By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)

6.2.4.     By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    North America Eye Drop Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Drug Class

7.2.3.     By Disease Indication

7.2.4.     By Distribution Channel

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Eye Drop Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Drug Class

7.3.1.2.3.             By Disease Indication

7.3.1.2.4.             By Distribution Channel

7.3.2.     Canada Eye Drop Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Drug Class

7.3.2.2.3.             By Disease Indication

7.3.2.2.4.             By Distribution Channel

7.3.3.     Mexico Eye Drop Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Drug Class

7.3.3.2.3.             By Disease Indication

7.3.3.2.4.             By Distribution Channel

8.    Europe Eye Drop Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Drug Class

8.2.3.     By Disease Indication

8.2.4.     By Country

8.3.  Europe: Country Analysis

8.3.1.     Russia Federation Eye Drop Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Drug Class

8.3.1.2.3.             By Disease Indication

8.3.1.2.4.             By Distribution Channel

8.3.2.     United Kingdom Eye Drop Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Drug Class

8.3.2.2.3.             By Disease Indication

8.3.2.2.4.             By Distribution Channel

8.3.3.     Germany Eye Drop Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Drug Class

8.3.3.2.3.             By Disease Indication

8.3.3.2.4.             By Distribution Channel

8.3.4.     France Eye Drop Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Drug Class

8.3.4.2.3.             By Disease Indication

8.3.4.2.4.             By Distribution Channel

8.3.5.     Spain Eye Drop Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Drug Class

8.3.5.2.3.             By Disease Indication

8.3.5.2.4.             By Distribution Channel

8.3.6.     Italy Eye Drop Market Outlook

8.3.6.1.         Market Size & Forecast

8.3.6.1.1.             By Value

8.3.6.2.         Market Share & Forecast

8.3.6.2.1.             By Type

8.3.6.2.2.             By Drug Class

8.3.6.2.3.             By Disease Indication

8.3.6.2.4.             By Distribution Channel

9.    Asia-Pacific Eye Drop Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Drug Class

9.2.3.     By Disease Indication

9.2.4.     By Distribution Channel

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Eye Drop Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Drug Class

9.3.1.2.3.             By Disease Indication

9.3.1.2.4.             By Distribution Channel

9.3.2.     India Eye Drop Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Drug Class

9.3.2.2.3.             By Disease Indication

9.3.2.2.4.             By Distribution Channel

9.3.3.     Japan Eye Drop Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Drug Class

9.3.3.2.3.             By Disease Indication

9.3.3.2.4.             By Distribution Channel

9.3.4.     Australia Eye Drop Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Drug Class

9.3.4.2.3.             By Disease Indication

9.3.4.2.4.             By Distribution Channel

9.3.5.     South Korea Eye Drop Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Drug Class

9.3.5.2.3.             By Disease Indication

9.3.5.2.4.             By Distribution Channel

9.3.6.     Indonesia Eye Drop Market Outlook

9.3.6.1.         Market Size & Forecast

9.3.6.1.1.             By Value

9.3.6.2.         Market Share & Forecast

9.3.6.2.1.             By Type

9.3.6.2.2.             By Drug Class

9.3.6.2.3.             By Disease Indication

9.3.6.2.4.             By Distribution Channel

10.  South America Eye Drop Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Drug Class

10.2.3.  By Disease Indication

10.2.4.  By Distribution Channel

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Eye Drop Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Drug Class

10.3.1.2.3.           By Disease Indication

10.3.1.2.4.           By Distribution Channel

10.3.2.  Argentina Eye Drop Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Drug Class

10.3.2.2.3.           By Disease Indication

10.3.2.2.4.           By Distribution Channel

10.3.3.  Colombia Eye Drop Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Drug Class

10.3.3.2.3.           By Disease Indication

10.3.3.2.4.           By Distribution Channel

11.  Middle East and Africa Eye Drop Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Drug Class

11.2.3.  By Disease Indication

11.2.4.  By Distribution Channel

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  Turkey Eye Drop Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Drug Class

11.3.1.2.3.           By Disease Indication

11.3.1.2.4.           By Distribution Channel

11.3.2.  South Africa Eye Drop Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Drug Class

11.3.2.2.3.           By Disease Indication

11.3.2.2.4.           By Distribution Channel

11.3.3.  Saudi Arabia Eye Drop Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Drug Class

11.3.3.2.3.           By Disease Indication

11.3.3.2.4.           By Distribution Channel

11.3.4.  UAE Eye Drop Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Drug Class

11.3.4.2.3.           By Disease Indication

11.3.4.2.4.           By Distribution Channel

11.3.5.  Kuwait Eye Drop Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Type

11.3.5.2.2.           By Drug Class

11.3.5.2.3.           By Disease Indication

11.3.5.2.4.           By Distribution Channel

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Johnson & Johnson Inc.

14.2.              Genentech, Inc. (Roche)

14.3.              Alcon Inc.

14.4.              Pfizer, Inc.

14.5.              Bausch Health Companies, Inc.

14.6.              Bayer Corporation

14.7.              Allergan, Inc. (AbbVie)

14.8.              Abbott Laboratories Inc.

14.9.              KC Pharmaceuticals, Inc.

14.10.            Akorn, Inc.

15.  Strategic Recommendations

Figures and Tables

List of Figures:

Figure 1: Global Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 2: Global Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 3: Global Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 4: Global Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 5: Global Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 6: Global Eye Drop Market Share, By Region, By Value, 2017-2027F

Figure 7: Global Eye Drop Market Share, By Company, By Value, 2021

Figure 8: Global Eye Drop Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2021

Figure 9: Global Eye Drop Market Map, By Drug Class, Market Size (USD Million) & Growth Rate (%), 2021

Figure 10: Global Eye Drop Market Map, By Disease Indication, Market Size (USD Million) & Growth Rate (%), 2021

Figure 11: Global Eye Drop Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021

Figure 12: Global Eye Drop Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021

Figure 13: North America Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 14: North America Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 15: North America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 16: North America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 17: North America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 18: North America Eye Drop Market Share, By Country, By Value, 2017-2027F

Figure 19: United States Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 20: United States Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 21: United States Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 22: United States Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 23: United States Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 24: Canada Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 25: Canada Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 26: Canada Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 27: Canada Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 28: Canada Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 29: Mexico Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 30: Mexico Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 31: Mexico Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 32: Mexico Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 33: Mexico Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 34: Europe Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 35: Europe Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 36: Europe Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 37: Europe Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 38: Europe Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 39: Europe Eye Drop Market Share, By Country, By Value, 2017-2027F

Figure 40: Russia Federation Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 41: Russia Federation Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 42: Russia Federation Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 43: Russia Federation Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 44: Russia Federation Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 45: United Kingdom Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 46: United Kingdom Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 47: United Kingdom Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 48: United Kingdom Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 49: United Kingdom Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 50: Germany Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 51: Germany Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 52: Germany Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 53: Germany Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 54: Germany Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 55: France Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 56: France Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 57: France Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 58: France Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 59: France Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 60: Spain Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 61: Spain Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 62: Spain Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 63: Spain Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 64: Spain Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 65: Italy Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 66: Italy Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 67: Italy Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 68: Italy Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 69: Italy Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 70: Asia-Pacific Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 71: Asia-Pacific Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 72: Asia-Pacific Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 73: Asia-Pacific Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 74: Asia-Pacific Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 75: Asia-Pacific Eye Drop Market Share, By Country, By Value, 2017-2027F

Figure 76: China Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 77: China Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 78: China Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 79: China Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 80: China Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 81: India Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 82: India Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 83: India Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 84: India Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 85: India Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 86: Japan Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 87: Japan Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 88: Japan Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 89: Japan Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 90: Japan Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 91: Australia Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 92: Australia Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 93: Australia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 94: Australia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 95: Australia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 96: South Korea Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 97: South Korea Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 98: South Korea Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 99: South Korea Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 100: South Korea Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 101: Indonesia Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 102: Indonesia Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 103: Indonesia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 104: Indonesia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 105: Indonesia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 106: South America Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 107: South America Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 108: South America Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 109: South America Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 110: South America Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 111: South America Eye Drop Market Share, By Country, By Value, 2017-2027F

Figure 112: Brazil Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 113: Brazil Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 114: Brazil Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 115: Brazil Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 116: Brazil Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 117: Argentina Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 118: Argentina Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 119: Argentina Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 120: Argentina Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 121: Argentina Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 122: Colombia Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 123: Colombia Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 124: Colombia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 125: Colombia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 126: Colombia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 127: Middle East & Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 128: Middle East & Africa Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 129: Middle East & Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 130: Middle East & Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 131: Middle East & Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 132: Middle East & Africa Eye Drop Market Share, By Country, By Value, 2017-2027F

Figure 133: Turkey Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 134: Turkey Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 135: Turkey Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 136: Turkey Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 137: Turkey Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 138: South Africa Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 139: South Africa Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 140: South Africa Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 141: South Africa Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 142: South Africa Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 143: Saudi Arabia Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 144: Saudi Arabia Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 145: Saudi Arabia Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 146: Saudi Arabia Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 147: Saudi Arabia Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 148: UAE Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 149: UAE Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 150: UAE Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 151: UAE Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 152: UAE Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Figure 153: Kuwait Eye Drop Market Size, By Value (USD Million), 2017-2027F

Figure 154: Kuwait Eye Drop Market Share, By Type, By Value, 2017-2027F

Figure 155: Kuwait Eye Drop Market Share, By Drug Class, By Value, 2017-2027F

Figure 156: Kuwait Eye Drop Market Share, By Disease Indication, By Value, 2017-2027F

Figure 157: Kuwait Eye Drop Market Share, By Distribution Channel, By Value, 2017-2027F

Frequently asked questions

down-arrow

The Market Size of Eye Drop Market in Europe was USD4044.12 million in 2021.

down-arrow

The market share of prescription-based eye drops in 2021 was 63.50%.

down-arrow

The major factors include risk of side effects associated with ophthalmic eye drops & lubricants and stringent rules & regulations.

down-arrow

The major factors driving the growth of Global Eye Drop Market include rise in prevalence of ophthalmic disorders worldwide and change in the demographics across the globe. In addition, drug discovery & development are expected to boost the market growth during the forecast period.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Eye Drop Market to Surpass USD19758 Million by 2027

Apr, 2022

Rising prevalence of ophthalmic disorders and eye infection is driving the growth in global eye market in the forecast period, 2023-2027.

Why Choose Us